Literature DB >> 11998554

Adverse drug reactions as a cause for admissions to a department of internal medicine.

Tom Mjörndal1, Marit Danell Boman, Staffan Hägg, Martin Bäckström, Bengt-Erik Wiholm, Anders Wahlin, Rune Dahlqvist.   

Abstract

PURPOSE: To assess the occurrence and pattern of adverse drug reactions as a cause for acute hospital admission.
METHODS: In 681 randomly selected patients, acutely admitted to a clinic of internal medicine at a Swedish university hospital, information was collected from their medical records about current symptoms and use of drugs, previous diseases and the results of medical investigations and tests. In addition, a standardized interview according to a questionnaire was carried out. A group of experts in clinical pharmacology assessed the data obtained from the patients' case records and the results of the interviews, and then, according to WHO criteria, judged the probability that an adverse drug reaction could have caused or contributed to the actual admission to hospital.
RESULTS: Out of the 681 cases included, 94 (13.8%) had symptoms and signs that were judged as drug-related and that had caused or contributed to the admission. Eighty-two patients (12.0%) had altogether 99 symptoms that were classified as adverse drug reactions. Of these, 91% were type A reactions. The relationship between the medication and the reaction was judged certain in eight, probable in 17, and possible in 74 cases. The most common adverse drug reactions were cardiovascular (36.3%). Twelve patients (1.8%) had symptoms indicating intoxications.
CONCLUSIONS: The prevalence of drug-related problems causing or contributing to admission to a clinic of internal medicine is high and is dominated by type A reactions, i.e. reactions in principle predictable and preventable. This implies a possibility to increase drug safety by preventive measures.

Entities:  

Mesh:

Year:  2002        PMID: 11998554     DOI: 10.1002/pds.667

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  82 in total

1.  Drug-drug interaction through molecular structure similarity analysis.

Authors:  Santiago Vilar; Rave Harpaz; Eugenio Uriarte; Lourdes Santana; Raul Rabadan; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2012-05-30       Impact factor: 4.497

2.  A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities.

Authors:  Thilo Bertsche; Carolin Veith; Alexander Stahl; Torsten Hoppe-Tichy; F Joachim Meyer; Hugo A Katus; Walter E Haefeli
Journal:  Pharm World Sci       Date:  2010-08-07

3.  Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.

Authors:  Sara Modig; Lydia Holmdahl; Åsa Bondesson
Journal:  Int J Clin Pharm       Date:  2015-11-18

4.  Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Authors:  Maria Cristina G Passarelli; Wilson Jacob-Filho; Albert Figueras
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

Authors:  M Bäckström; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2006-03-30       Impact factor: 2.953

6.  Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

Authors:  Cornelis S van der Hooft; Miriam C J M Sturkenboom; Kees van Grootheest; Herre J Kingma; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  Adverse drug reaction reporting by nurses in Sweden.

Authors:  M Bäckström; Elisabet Ekman; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2007-04-03       Impact factor: 2.953

9.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

10.  Handling Temporality of Clinical Events for Drug Safety Surveillance.

Authors:  Jing Zhao; Aron Henriksson; Maria Kvist; Lars Asker; Henrik Boström
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.